This inventor holds 4 USPTO granted patents. Top assignee: Mcneil-Ppc, Inc.. Active years: 2000-2005.
Company Filing History:
Years Active: 2000-2005
Title: The Innovative Contributions of Robert T. McFadden
Introduction
Robert T. McFadden is a notable inventor based in Congers, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of lactase tablets. With a total of 4 patents to his name, McFadden's work has had a meaningful impact on the industry.
Latest Patents
One of McFadden's latest patents is for a preblend of microcrystalline cellulose and lactase for making tablets. This innovative preblend contains about 1-99% (preferably about 20-60%) by weight lactase and about 1-99% (preferably about 40-80%) by weight microcrystalline cellulose. The lactase used in the preblend may be combined with cutting agents such as sugars, starches, cellulose, and inorganic salts. Additionally, the preblend may include a lubricant like magnesium stearate. A preferred formulation contains about 9.6 weight percent lactase and about 90 weight percent microcrystalline cellulose, or about 2000 to about 9000 FCC lactase units. Another formulation includes about 9.6 weight percent lactase, about 30.0 weight percent microcrystalline cellulose, and about 59.4 weight percent mannitol.
Career Highlights
Robert T. McFadden is currently associated with McNeil-PPC, Inc., where he continues to innovate in the field of pharmaceutical formulations. His work has been instrumental in enhancing the effectiveness and stability of lactase tablets.
Collaborations
Throughout his career, McFadden has collaborated with notable colleagues such as Sunanda R. Kulkarni and David H. Rogers. These collaborations have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Robert T. McFadden's contributions to the field of pharmaceuticals, particularly in the development of lactase tablets, showcase his innovative spirit and dedication to improving health solutions. His patents reflect a commitment to enhancing the effectiveness of pharmaceutical products.